Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Vernalis diabetes pain drug fails in phase II

March 24, 2010 Research and Development Vernalis

Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …
News

Adverse event halts Merck cancer vaccine trial

March 23, 2010 Research and Development Merck KGaA, Merck Serono, Stimuvax, vaccines

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …
News

PPD boosts position in flu vaccine research

March 23, 2010 Research and Development CRO, PPD, Southern Research Institute, vaccines

PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …
News

CHMP in brief: Hospira’s Nivestim approved

March 22, 2010 Research and Development EMA

A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …
News

Pfizer’s Kindler elected PhRMA chairman

March 22, 2010 Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing

Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …
Appointment

Merck joins coalition for biosecurity vaccine plant

March 22, 2010 Manufacturing and Production, Research and Development biodefence, vaccines

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …
News

Novelos abandons candidate in lung cancer

March 20, 2010 Research and Development NSCLC, breast cancer

 
News

Baxter Alzheimer’s candidate shows promise

March 20, 2010 Research and Development Alzheimer's, baxter

Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …
News

GSK’s Relovair moves into phase III

March 19, 2010 Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory

GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …
News

Cephalon to develop new class of cancer drug

March 19, 2010 Research and Development CRT, Cancer, Cancer Research UK, Cephalon

Pennsylvania-based Cephalon has signed a deal with the discovery arm of charity Cancer Research UK to develop a new class …
News

Talking Point: Responding to trial emergencies

March 19, 2010 Research and Development Talking Point, Talking R&D, research and development

Patients taking part in a clinical trial will sometimes experience a medical emergency, at which point the potential need to …
Feature

Tekturna fails to show heart attack benefit

March 17, 2010 Research and Development Diovan, Novartis, Tekturna, hypertension

Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …
News

Study boost for atrial fibrillation drugs

March 17, 2010 Research and Development Pradaxa, VTE, Xarelto, apixaban, betrixaban

Two rival drugs have both shown benefits over warfarin in patients with atrial fibrillation, according to new research. Boehringer Ingelheim’s …
News

WuXi’s growth slows

March 17, 2010 Research and Development CRO, China, WuXi

WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …
News
William Burns

Bill Burns joins Shire board

March 17, 2010 Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing

Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026